Diversity, Equity, and Inclusion in the Drug Development Lifecycle Meeting

Agenda

Day 1 Apr 27, 2021

10:00 AM — 10:30 AM

Welcoming Remarks and Keynote Address

10:30 AM — 11:30 AM

Session 1: Increasing Diversity in Drug Discovery and Early Development

11:30 AM — 11:45 AM

BREAK

11:45 AM — 12:45 PM

Session 2: Exploring the Role of IRBs and IECs in Assuring Appropriate Representation in Research and Development

12:45 PM — 1:15 PM

BREAK

1:15 PM — 2:30 PM

Session 3a: Change Management – From Insights Into Action

1:15 PM — 2:30 PM

2:30 PM — 2:45 PM

BREAK

2:45 PM — 4:00 PM

Session 4: Clinical Trial Diversity and Inclusion: Perspectives from FDA, Industry, and Clinical Research Sites

4:00 PM — 4:15 PM

BREAK

4:15 PM — 5:15 PM

5:15 PM — 5:45 PM

Networking Lounge

5:45 PM — 5:45 PM

Conference Adjourns

Have an account?